CareMax Future Growth
Future criteria checks 1/6
CareMax is forecast to grow earnings and revenue by 73.7% and 14.4% per annum respectively while EPS is expected to grow by 80.2% per annum.
Key information
73.7%
Earnings growth rate
80.2%
EPS growth rate
Healthcare earnings growth | 17.2% |
Revenue growth rate | 14.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 05 Jun 2024 |
Recent future growth updates
Recent updates
CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity
Jun 20Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results
May 13Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%
Mar 11CareMax: Numbers Are Strong, Compelling Value On Offer
Sep 16CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M
Aug 09CareMax: Steward Health Care Acquisition Highlights Growth Ambitions
Jul 02CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries
Oct 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,128 | -62 | 6 | 17 | 1 |
12/31/2025 | 1,071 | -103 | -51 | -43 | 3 |
12/31/2024 | 892 | -144 | 2 | 11 | 1 |
3/31/2024 | 810 | -645 | -61 | -49 | N/A |
12/31/2023 | 751 | -683 | -62 | -47 | N/A |
9/30/2023 | 764 | -207 | -101 | -91 | N/A |
6/30/2023 | 719 | -126 | -94 | -84 | N/A |
3/31/2023 | 667 | -103 | -86 | -78 | N/A |
12/31/2022 | 631 | -38 | -76 | -68 | N/A |
9/30/2022 | 585 | -52 | -61 | -55 | N/A |
6/30/2022 | 532 | -44 | -54 | -48 | N/A |
3/31/2022 | 405 | -25 | -43 | -39 | N/A |
12/31/2021 | 296 | -7 | -28 | -24 | N/A |
9/30/2021 | 206 | -2 | -13 | -9 | N/A |
6/30/2021 | 125 | 12 | -4 | -2 | N/A |
3/31/2021 | 106 | 6 | 5 | 7 | N/A |
12/31/2020 | 103 | 8 | 3 | 5 | N/A |
9/30/2020 | 101 | 7 | 5 | 8 | N/A |
12/31/2019 | 91 | 6 | 6 | 7 | N/A |
12/31/2018 | 72 | 3 | 0 | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CMAX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CMAX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CMAX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CMAX's revenue (14.4% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: CMAX's revenue (14.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CMAX's Return on Equity is forecast to be high in 3 years time